{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-004019","form_type":"8-K","ticker":"CMPX","cik":"0001738021","company_name":"Compass Therapeutics, Inc.","filed_at":"2022-05-31T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.069540+00:00","generated_at":"2026-06-25T05:57:45.529446+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Compass Therapeutics stockholders elect directors and ratify auditor at 2022 annual meeting","bullets":["Philip J. Ferneau re-elected with 57.0M votes for, 8.5M withheld; Carl L. Gordon with 55.5M for, 10.0M withheld.","Ratification of CohnReznick LLP as auditor for FY 2022 passed with 82.3M for, 65,654 against, 5,702 abstain.","No other proposals or material changes disclosed at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-004019","json":"https://secwatch.observer/filing/0001171843-22-004019.json","markdown":"https://secwatch.observer/filing/0001171843-22-004019.md","text":"https://secwatch.observer/filing/0001171843-22-004019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1738021/000117184322004019/0001171843-22-004019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1738021/000117184322004019/f8k_053122.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:57:45.529446+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}